Jingrong Jean Cui, Chief Scientific Officer at Turning Point Therapeutics, Inc. (TPTX), sold 34,500 shares at $53.79 ($1.9M) on 2019-12-10, disclosed to the SEC on 2019-12-12.
Open-market sale of $1.9M TPTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.79 | 2,700 | $145K | 7.8% |
| 2 | $54.81 | 8,700 | $477K | 25.7% |
| 3 | $55.51 | 100 | $6K | 0.3% |
| 4 | $52.72 | 8,928 | $471K | 25.3% |
| 5 | $53.67 | 2,452 | $132K | 7.1% |
| 6 | $54.20 | 120 |
| $7K |
| 0.3% |
| 7 | $53.18 | 500 | $27K | 1.4% |
| 8 | $54.15 | 10,900 | $590K | 31.8% |
| 9 | $54.66 | 100 | $5K | 0.3% |
| Total | $53.88 avg | 34,500 | $1.9M | 100% |
| Filing → |
| TPTX | SELL | 2020-05-21 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-12 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-07 | $5.8M | — | Filing → |